Seyed-Moayed Alavian MD 1, Masoud Ahmadzad Asl MD 2, Maryam Keshvari MD 3, Bita Behnava MD 4, Bashir Hajibeigi MD 5 1 Associate Professor of Gastroenterology; Department of Gastroenterology, Baqiyatallah University of Medical Sciences; Dean of Tehran Hepatitis Center, Tehran, Iran 2 Methodology and Statistics Consultant; Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Iran ...

results the results of this study indicated that the overall hepatitis b vaccine acceptance rate was acceptably high. among all, 53.5% correctly identified that a vaccine to prevent hepatitis b virus infection had been available, 15% had a negative opinion, and 31.5% were neutral. the rations of all three doses of vaccination were 69.3%. conclusions among the respondents, 87% were currently mar...

abstract        background and objective: this study was conducted to evaluate epidemiology of risk factors for hepatitis c virus (hcv) transmission, and determine the association of its genotypes with viral load and response to treatment in patients referred to the infectious disease clinic of khorramabad.         methods: the study included patients infected with hepatitis c referred to the i...

Abstract Hepatitis B virus infection is one of the most common diseases diagnosed and treated in infectious disease hospitals around world, with about 5% world’s population infected this virus. In 2020, 21 cases acute hepatitis were registered Romania no case perinatal transmission or chronic B, maximum incidence rate women was among those aged between 45 54 years, men 20 24 years. This study a...

A review of the literature relating to the need for vaccination against infectious disease in the solid waste industry was conducted, focusing on hepatitis A, hepatitis B and tetanus. Databases (Medline, PreMedline, EMBASE, CINAHL, Current Contents, Cochrane Database, HTA Database, DARE, OSHROM) were searched up to and including August 2003. Articles were included in the review if they reported...

Blood donations in England and Wales are collected from healthy donors who do not acknowledge factors associated with an increased risk of bloodborne infections. All donations issued for transfusion since the early 1970s have been tested for hepatitis B surface antigen as a marker of transmissible hepatitis B virus. These measures have resulted in low rates of transmission by transfusion but ha...